1.Clinical features of chronic granulomatous disease.
Wen-jing YING ; Xiao-chuan WANG ; Jin-qiao SUN ; Dan-ru LIU ; Ye-heng YU ; Jing-yi WANG
Chinese Journal of Pediatrics 2012;50(5):380-385
OBJECTIVEChronic granulomatous disease (CGD) is a rare primary immunodeficiency of phagocytic oxidative bursts leading to recurrent severe bacterial and fungal infections as well as granuloma formation. There were few reports on the clinical characteristics of this disease in China. The purpose of this study was to evaluate the clinical features of 48 Chinese cases with CGD which were confirmed by clinical features, dihydrorhodamine (DHR) assay and gene mutation analysis.
METHODThe study cohort was the population of CGD patients diagnosed in Children's Hospital of Fudan University from January, 2004, to June, 2011. Cases included in our analysis were restricted to those who had complete data of the clinical symptoms and laboratory tests. The patients were followed up by outpatient visiting and telephone call regularly for 0.5 to 6 years. The history and data of physical examination and treatment of 48 cases were collected and reviewed.
RESULTAll the patients were diagnosed by DHR analysis. The age of onset of all the 48 patients were less than 6 months, including 43 male and 5 female. The mean age at diagnosis was 2.42 years; 12 patients were infants under six months, 10 were between 6 and 12 months, 9 were between 1 and 2 years, 5 patients were between 2 and 3 years, 4 were between 4 and 5 years, and 8 were between 6 and 10 years. Recurrent respiratory infection (44/48) and chronic diarrhea (31/48) were the common symptoms in all the patients, and then skin lesion (22/48), including marked reaction at BCG infected site, pustular eruption and infected skin ulcer and urinary tract infection (3/48) were also general symptoms in our study. In addition, lymphadenectasis occurred in 31 cases and 23 of them were considered to be associated with BCG vaccination. The pathogens caused the infection were mycobacteria (52.08%), fungi (43.75%) and pyogenic bacteria. Thirty-seven patients had mutations in CYBB/CYBA/NCF1/NCF2 genes. Recombinant human interferon-gamma (rhIFN-γ) plus sulfamethoxazole were used for the prevention and treatment of infection, the frequency and severity of the disease could be reduced.
CONCLUSIONThe age at onset and diagnosis of the present group of CGD was younger. Clinical symptoms were associated with recurrent mycobacterial, fungal and pyogenic bacterial infection, which involved respiratory tract, alimentary tract, skin and lymph node. rhIFN-γ partially improved the prognosis of CGD.
Bacterial Infections ; epidemiology ; etiology ; prevention & control ; Child ; Child, Preschool ; Female ; Gastrointestinal Diseases ; epidemiology ; etiology ; prevention & control ; Granulomatous Disease, Chronic ; complications ; diagnosis ; genetics ; Humans ; Infant ; Interferon-gamma ; therapeutic use ; Lung Diseases ; epidemiology ; etiology ; prevention & control ; Male ; Mutation ; Mycobacterium Infections ; epidemiology ; etiology ; prevention & control ; Recombinant Proteins ; Retrospective Studies ; Skin Diseases ; epidemiology ; etiology ; prevention & control
2.Febrile Urinary Tract Infection After Prostate Biopsy and Quinolone Resistance.
Joong Won CHOI ; Tae Hyoung KIM ; In Ho CHANG ; Kyung Do KIM ; Young Tae MOON ; Soon Chul MYUNG ; Jin Wook KIM ; Min Su KIM ; Jong Kyou KWON
Korean Journal of Urology 2014;55(10):660-664
PURPOSE: Complications after prostate biopsy have increased and various causes have been reported. Growing evidence of increasing quinolone resistance is of particular concern. In the current retrospective study, we evaluated the incidence of infectious complications after prostate biopsy and identified the risk factors. MATERIALS AND METHODS: The study population included 1,195 patients who underwent a prostate biopsy between January 2007 and December 2012 at Chung-Ang University Hospital. Cases of febrile UTI that occurred within 7 days were investigated. Clinical information included age, prostate-specific antigen, prostate volume, hypertension, diabetes, body mass index, and biopsy done in the quinolone-resistance era. Patients received quinolone (250 mg intravenously) before and after the procedure, and quinolone (250 mg) was orally administered twice daily for 3 days. We used univariate and multivariate analysis to investigate the predictive factors for febrile UTI. RESULTS: Febrile UTI developed in 39 cases (3.1%). Core numbers increased from 2007 (8 cores) to 2012 (12 cores) and quinolone-resistant bacteria began to appear in 2010 (quinolone-resistance era). In the univariate analysis, core number> or =12 (p=0.024), body mass index (BMI)>25 kg/m2 (p=0.004), and biopsy done in the quinolone-resistance era (p=0.014) were significant factors. However, in the multivariate analysis adjusted for core number, the results were not significant, with the exception of BMI>25 kg/m2 (p=0.011) and biopsy during the quinolone-resistance era (p=0.035), which were significantly associated with febrile UTI. CONCLUSIONS: Quinolone resistance is the main cause of postbiopsy infections in our center. We suggest that further evaluation is required to validate similar trends. Novel strategies to find alternative prophylactic agents are also necessary.
Aged
;
Anti-Bacterial Agents/*therapeutic use
;
Antibiotic Prophylaxis/methods
;
Cross Infection/etiology/prevention & control
;
*Drug Resistance, Bacterial
;
Fluoroquinolones/*therapeutic use
;
Humans
;
Image-Guided Biopsy/*adverse effects/methods
;
Incidence
;
Male
;
Middle Aged
;
Prostatic Neoplasms/*pathology
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Risk Factors
;
Ultrasonography, Interventional
;
Urinary Tract Infections/epidemiology/*etiology/prevention & control
3.Application of Damage Control Resuscitation Strategies to Patients with Severe Traumatic Hemorrhage: Review of Plasma to Packed Red Blood Cell Ratios at a Single Institution.
Younghwan KIM ; Kiyoung LEE ; Jihyun KIM ; Jiyoung KIM ; Yunjung HEO ; Heejung WANG ; Kugjong LEE ; Kyoungwon JUNG
Journal of Korean Medical Science 2014;29(7):1007-1011
When treating trauma patients with severe hemorrhage, massive transfusions are often needed. Damage control resuscitation strategies can be used for such patients, but an adequate fresh frozen plasma: packed red blood cell (FFP:PRBC) administration ratio must be established. We retrospectively reviewed the medical records of 100 trauma patients treated with massive transfusions from March 2010 to October 2012. We divided the patients into 2 groups according to the FFP:PRBC ratio: a high-ratio (> or =0.5) and a low-ratio group (<0.5). The patient demographics, fluid and transfusion quantities, laboratory values, complications, and outcomes were analyzed and compared. There were 68 patients in the high-ratio and 32 in the low-ratio group. There were statistically significant differences between groups in the quantities of FFP, FFP:PRBC, platelets, and crystalloids administered, as well as the initial diastolic blood pressure. Bloodstream infections were noted only in the high-ratio group, and the difference was statistically significant (P=0.028). Kaplan-Meier plots revealed that the 24-hr survival rate was significantly higher in the high-ratio group (71.9% vs. 97.1%, P<0.001). In severe hemorrhagic trauma, raising the FFP:PRBC ratio to 0.5 or higher may increase the chances of survival. Efforts to minimize bloodstream infections during the resuscitation must be increased.
Acute Lung Injury/epidemiology/etiology
;
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Bacterial Infections/epidemiology
;
*Blood Transfusion/adverse effects
;
*Erythrocyte Transfusion/adverse effects
;
Female
;
Hemorrhage/etiology/*prevention & control
;
Hospital Mortality
;
Humans
;
Kaplan-Meier Estimate
;
Male
;
Middle Aged
;
Patients
;
Respiratory Distress Syndrome, Adult/epidemiology/etiology
;
Resuscitation
;
Retrospective Studies
;
Wounds and Injuries/complications/mortality/*therapy
;
Young Adult
4.Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy.
Chunwoo LEE ; Dalsan YOU ; In Gab JEONG ; Jun Hyuk HONG ; Myung Soo CHOO ; Hanjong AHN ; Tai Young AHN ; Choung Soo KIM
Korean Journal of Urology 2015;56(6):466-472
PURPOSE: To assess the rates of infectious complications before and after the change of prophylactic antibiotic regimens in prostate needle biopsy. MATERIALS AND METHODS: The records of 5,577 patients who underwent prostate needle biopsy at Asan Medical Center between August 2005 and July 2012 were retrospectively reviewed. Group 1 (n=1,743) included patients treated between 2005 and 2009 with fluoroquinolone for 3 days, group 2 (n=2,723) included those treated between 2009 and 2012 with ceftriaxone once before the biopsy and fluoroquinolone before biopsy and continue therapy for 3 days, and group 3 (n=1,111) received the same treatment for more than 7 days after the biopsy. Univariable and multivariable logistic regression models addressed risk factors associated with infectious complication after prostate needle biopsy. RESULTS: Infectious complication after prostate needle biopsy developed in 18 (group 1), seven (group 2), and two patients (group 3) (p=0.001). In group 1, seven patients with infectious complication had positive blood cultures and harbored fluoroquinolone-resistant Escherichia coli, four had ceftriaxone susceptible isolates, and three had extended spectrum beta-lactamase-positive E. coli. Two patients in group 1 required intensive care because of septic shock. In multivariable analysis, the patients with combination of fluoroquinolone and ceftriaxone had significantly lower infectious complication rate than the fluoroquinolon alone (p=0.003). CONCLUSIONS: Antibiotic prophylaxis with ceftriaxone and fluoroquinolone before prostate needle biopsy decreased the risk of potentially serious infectious complications.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Antibiotic Prophylaxis/*methods
;
Biopsy, Needle/adverse effects/methods
;
Ceftriaxone/*therapeutic use
;
Cross Infection/epidemiology/etiology/*prevention & control
;
Drug Evaluation/methods
;
Drug Resistance, Bacterial
;
Drug Therapy, Combination
;
Escherichia coli/drug effects
;
Escherichia coli Infections/epidemiology/prevention & control
;
Fluoroquinolones/*therapeutic use
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Prostatic Neoplasms/*pathology
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Ultrasonography, Interventional
;
Young Adult
5.Selective Bowel Decontamination for the Prevention of Infection in Acute Myelogenous Leukemia: A Prospective Randomized Trial.
Dong Gun LEE ; Su Mi CHOI ; Jung Hyun CHOI ; Jin Hong YOO ; Yoon Hee PARK ; Yoo Jin KIM ; Seok LEE ; Chang Ki MIN ; Hee Je KIM ; Dong Wook KIM ; Jong Wook LEE ; Woo Sung MIN ; Wan Shik SHIN ; Chun Choo KIM
The Korean Journal of Internal Medicine 2002;17(1):38-44
BACKGROUND: Infection is still a frequent cause of morbidity and mortality in acute myelogenous leukemia (AML) patients receiving chemotherapy. Recently the main cause of infection has changed from gram-negative to gram-positive bacteria and the resistance to antibiotics has increased. This study aimed to access the effectiveness of antimicrobial prophylaxis (AP) with orally absorbable antibiotics. METHODS: Ninety-five AML patients receiving chemotherapy at Catholic Hemopoietic Stem Cell Transplantation Center from March 1999 to July 1999 were randomly divided into the AP group (250 mg ciprofloxacin twice a day, 150 mg roxithromycin twice a day, 50 mg fluconazole once a day) and the control group for a prospective analysis. RESULTS: The incidence of fever was 82.6% in the AP group and 91.6% in the control group (p=0.15). Though classification and sites of infections showed no difference between the two groups, the catheter associated infection occurred more frequently in the AP group in significance. The time interval between initiation of chemotherapy and onset of fever, white blood cell (WBC) count at the onset of fever, duration of leukopenia (WBC < 1,000/mm ), duration of systemic antibiotic therapy, mortality due to infection and hospitalization period from the data starting chemotherapy showed no differences between the two groups. Infections due to gram negative bacteria decreased to 33.3% in the AP group (vs. 92% in the control group), but infections due to gram positive bacteria increased to 66.7% (vs. 8% in the control group). Gram negative bacteria showed 100% resistance to ciprofloxacin in the AP group and gram-positive bacteria showed 90-100% resistance to erythromycin, regardless of the presence of AP. CONCLUSION: The AP could not reduce the occurrence of infection or infection associated death in AML patients receiving chemotherapy. On considering increased gram-positive infection and resistance to fluoroquinolone and macrolide, routine prescription of AP should be reconsidered. Further studies that assess the effectiveness of AP in other malignancies, aplastic anemia and bone marrow transplantation are required.
Adult
;
Anti-Infective Agents, Fluoroquinolone/*therapeutic use
;
*Antibiotic Prophylaxis
;
Bacterial Infections/epidemiology/etiology/*prevention & control
;
Ciprofloxacin/*therapeutic use
;
Drug Therapy, Combination
;
Female
;
Fever/epidemiology/etiology
;
Fluconazole/therapeutic use
;
Human
;
Incidence
;
Leukemia, Myelocytic, Acute/*complications/drug therapy
;
Male
;
Middle Age
;
Neutropenia/chemically induced/*complications
;
Prospective Studies
;
Roxithromycin/therapeutic use
;
Treatment Outcome
6.Analysis of the prognosis and clinical factors in primary vesicoureteral reflux patients.
Jing XU ; Hong XU ; Li-jun ZHOU ; Qian SHEN ; Li SUN ; Yun-li BI ; Xiang WANG
Chinese Journal of Pediatrics 2012;50(8):587-592
OBJECTIVETo analyze the relationship between the prognosis and clinical factors of primary vesicoureteral reflux (VUR) patients under the condition of non-surgical treatment.
METHODThe medical records of the patients who were diagnosed as VUR by micturating cystourethrography (MCU) from January 2000 to December 2009 in Children's Hospital of Fudan University underwent non-surgical treatment, and followed up for more than one year then had repeated MCU, were retrospectively reviewed.
RESULTA total of 73 children (30 boys, 43 girls) were included in this study. The percentage of mild reflux (grade I-II) was 19.2% (14/73), that of moderate reflux (grade III) was 53.4% (39/73), and that of severe reflux (grade IV-V) was 27.4% (20/73). Among 73 patients, 27 (37.0%) patients were found to have renal damage. The average interval of repeated MCU was (1.29 ± 0.40) years (1 - 2 years). After follow-up, it was found that the reflux grade was relieved in 41 (56.2%) patients, of whom 27 (37.0%) patients achieved complete resolution, 32 (43.8%) patients did not have remission in reflux grade, of whom 13 (17.8%) patients had worsened reflux grade. Logistic regression analysis showed that VUR patients with renal damage at initial diagnosis was an important clinical factor to affect reflux remission (P = 0.000), complete resolving (P = 0.008) and result in worsening (P = 0.002).
CONCLUSIONA certain proportion of primary VUR patients could get reflux grade self-resolution, it was also quite common in severe VUR patients. VUR patients with renal damage at initial diagnosis was an important clinical factor affecting the reflux grade prognosis. Mild and moderate VUR patients with renal damage were at risk of worsening. VUR patients with high reflux grade had normal renal status could still get remission or even disappearance of VUR. But severe VUR patients with renal damage were still recommended to receive surgical therapy.
Anti-Bacterial Agents ; administration & dosage ; therapeutic use ; Child ; Child, Preschool ; Cicatrix ; Female ; Humans ; Infant ; Kidney Diseases ; epidemiology ; etiology ; pathology ; Male ; Prognosis ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; Survival Rate ; Urinary Tract Infections ; epidemiology ; etiology ; prevention & control ; Urography ; Vesico-Ureteral Reflux ; complications ; drug therapy ; pathology